Pancreatic cancer: The clinical trial landscape and progress for 2024
Pancreatic cancer faces resistance to conventional therapies, but cutting-edge research and new treatments are expected to improve survival rates and patient quality of life.
In Association With Novotech
Pancreatic cancer faces resistance to conventional therapies, but cutting-edge research and new treatments are expected to improve survival rates and patient quality of life.